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Pericentrin is an integral centrosomal component that anchors regulatory and structural molecules to centrosomes. In a
yeast two-hybrid screen with pericentrin we identified chromodomain helicase DNA-binding protein 4 (CHD4/Mi2).
CHD4 is part of the multiprotein nucleosome remodeling deacetylase (NuRD) complex. We show that many NuRD
components interacted with pericentrin by coimmunoprecipitation and that they localized to centrosomes and midbodies.
Overexpression of the pericentrin-binding domain of CHD4 or another family member (CHD3) dissociated pericentrin
from centrosomes. Depletion of CHD3, but not CHD4, by RNA interference dissociated pericentrin and -tubulin from
centrosomes. Microtubule nucleation/organization, cell morphology, and nuclear centration were disrupted in CHD3-
depleted cells. Spindles were disorganized, the majority showing a prometaphase-like configuration. Time-lapse imaging
revealed mitotic failure before chromosome segregation and cytokinesis failure. We conclude that pericentrin forms
complexes with CHD3 and CHD4, but a distinct CHD3–pericentrin complex is required for centrosomal anchoring of
pericentrin/-tubulin and for centrosome integrity.
INTRODUCTION
Centrosomes are the major microtubule organizing centers
in animal cells and play a pivotal role in cell cycle progres-
sion, bipolar spindle formation, and cytokinesis (Doxsey et
al., 2005). A centrosome consists of a pair of centrioles sur-
rounded by a protein matrix or pericentriolar material
(PCM). Pericentrin localizes to the PCM, and it is responsible
for anchoring both regulatory and structural proteins at the
centrosome (Doxsey et al., 1994). Several pericentrin-inter-
acting proteins have been identified including GCP2 and -3
of the -tubulin ring complex (-TuRC) (Dictenberg et al.,
1998; Zimmerman et al., 2004), the light intermediate chain
of cytoplasmic dynein (Purohit et al., 1999), the kinases
protein kinase (PK)A and PKCII (Diviani et al., 2000; Chen
et al., 2004; Zimmerman et al., 2004), CG-NAP/AKAP450
(Takahashi et al., 2002), DISC1 (Miyoshi et al., 2004), and
PCM-1 (Li et al., 2001). Pericentrin and its homologues in
yeast, Drosophila, and Aspergillus has been shown to be in-
volved in microtubule and spindle organization and func-
tion in some systems (Kilmartin and Goh, 1996; Purohit et al.,
1999; Flory et al., 2002; Kawaguchi and Zheng, 2004; Zimmerman
et al., 2004; Miyoshi et al., 2006) but not others (Martinez-
Campos et al., 2004). Pericentrin also seems to play a role in the
assembly/maintenance of primary cilia and flagella (Jurczyk et
al., 2004; Martinez-Campos et al., 2004; Mikule et al., 2007).
Chromodomain helicase DNA-binding (CHD) proteins are re-
lated by the presence of two chromatin organization modifier
domains (chromodomains), a SWI/SNF-type ATPase domain,
and DNA-binding motif. Chromodomains (30–50 amino acids)
mediate protein–DNA or protein–protein interactions (Brehm
et al., 2004). The human CHD family contains at least nine
members that can be grouped into subfamilies based on se-
quence homology: CHD1 and CHD2; CHD3, CHD4, and
CHD5; and CHD6–CHD9 (Woodage et al., 1997; Aubry et al.,
1998; Schuster and Stoger, 2002; Thompson et al., 2003; Flaus et
al., 2006). Homologues of CHD proteins have been found in
Saccharomyces cerevisiae, Schizosaccharomyces pombe, Drosophila
melanogaster, Caenorhabditis elegans, and Mus musculus (von
Zelewsky et al., 2000; Jae Yoo et al., 2002). A single CHD gene,
CHD1, is present in S. cerevesiae, whereas S. pombe contains two
genes, Hrp1 and Hrp3 (Jin et al., 1998; Tran et al., 2000; Yoo et
al., 2000; Jae Yoo et al., 2002). C. elegans and D. melanogaster both
possess at least two different CHD genes (Woodage et al., 1997).
CHD4, CHD3, or both have been found in multiple complexes,
including the nucleosome remodeling deacetylase (NuRD)
complex, a second complex regulating the deacetylation and
inactivation of p53, a third involved in loading cohesin onto
chromatin (Wade et al., 1998; Zhang et al., 1998; Luo et al., 2000;
Wang and Zhang, 2001; Hakimi et al., 2002), and a forth poten-
tially involved in the DNA damage response and silencing
genes involved regulating cell cycle progression (Schmidt and
Schreiber, 1999). In addition to CHD4 (and CHD3), the NuRD
complex contains: histone deacetylases 1 and -2, retinoblasti-
noma-associated proteins 46 and 48 (RbAp46/48), methyl-
CpG-binding domain-containing protein 3 (MBD3), and a me-
tastasis-associated protein (MTA) subunit (Tong et al., 1998;
Wade et al., 1998; Zhang et al., 1998; Bowen et al., 2004). CHD4
hydrolyzes ATP in a DNA-dependent manner in vitro, and this
activity is greatly increased when DNA is wrapped around
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histone octamers (nucleosomes) (Wang and Zhang, 2001). This
activity is thought to be important for the complex to act as a
transcriptional repressor, perhaps by using energy of ATP
hydrolysis to remodel nucleosomes. This could allow HDACs
to access and deacetylate histone acetyl-lysine residues,
thereby compacting nucleosomes and initiating transcriptional
repression. A NuRD complex containing MTA3 was identified
that regulates E-cadherin expression by controlling the expres-
sion of the negative regulator Snail (Fujita et al., 2004), thus
identifying the first gene regulated by the NuRD complex. It is
unclear whether the NuRD is a global repressor or a repressor
of a subset of genes. The NuRD complex characterized by
Fujita et al. (2004), which contained MTA3 exclusively, suggests
that MTA subunits might confer targeting specificity to the
complex and that the activity of the NuRD might be restricted
to the repression of specific genes. In this article, we identify an
interaction between pericentrin and CHD3/4 and other NuRD
components, and we suggest that these proteins form com-
plexes distinct from the NuRD. We show that CHD3, CHD4,
and MTA2 are components of the centrosome and that func-
tional abrogation of CHD3, and to some extent CHD4, disrupts
centrosome integrity and function, microtubule organization,
and mitotic progression.
MATERIALS AND METHODS
Yeast Two-Hybrid Screen
The yeast strain AH109 was transformed with a GAL4 DNA-binding domain
fusion vector, pGBKT7 (Clontech, Mountain View, CA), containing residues
1340-1756 of murine pericentrin. After determining that the GAL4 DBD/
pericentrin fusion failed to autotransactivate the reporter genes, a 50-ml
culture was grown overnight and then mated with the yeast strain Y187,
which had been pretransformed with a human testes cDNA library (Clon-
tech). Diploid clones were plated out onto to synthetic defined medium
lacking leucine, tryptophan, histidine, and adenine to select for positive
interactants.
cDNA Clones, Cloning Techniques, and Expression
Constructs
cDNAs encoding CHD3, CHD4, and pericentrin were obtained from the
following sources: CHD3 C-terminal sequence was from molecular analysis of
genomes and their expression (IMAGE) clone 642405 (IMAGE consortium);
CHD4 human testis cDNA library described above; and murine pericentrin as
described previously (Purohit et al., 1999). Sequences encoding pericentrin,
CHD3, and CHD4 were amplified by polymerase chain reaction (PCR) by
using Pfu Turbo DNA polymerase (Stratagene, La Jolla, CA), cloned into a
donor vector of the Creator system (Clontech), and sequenced to verify the
fidelity of the amplifying enzyme (Applied Biosystems, Foster City, CA).
Coding sequences were transferred, by Cre-mediated recombination, into a
range of expression vectors that included pLP-GBK-T7 (Clontech), pLP-CMV-
myc (Clontech), and an existing FLAG-tagged vector that was converted for
use with the system. The recombination protocol was as follows: 200 ng of
each vector (donor and acceptor) were incubated at 37°C for 1 h in 1 Cre
recombinase buffer with 1 U of Cre recombinase (New England Biolabs,
Ipswich, MA), the enzyme was then heat inactivated at 70°C for 5 min, and
the reaction was allowed to slowly cool to room temperature. Chemically
competent DH5 were transformed with 2 l of heat-inactivated recombina-
tion reaction.
Cell Culture and Transfection
COS and HeLa cells were cultured in DMEM supplemented with l-glutamine
and 10% fetal calf serum, whereas retinal pigment epithelial (RPE)-1 cells
(Clontech) were cultured in DMEM-F-12 supplemented with l-glutamine,
sodium bicarbonate, and 10% fetal calf serum (Invitrogen). Cells were trans-
fected either with Lipofectamine (Invitrogen, Carlsbad, CA) or by calcium
phosphate precipitation. COS were transiently transfected with 5 g of DNA
by using Lipofectamine Plus reagent (Invitrogen) according to the protocol
provided by the manufacturer. For immunofluorescent studies, 4  106 HeLa
or RPE cells were electroporated with 20 g of plasmid DNA in 500 l of
electroporation buffer (50 mM HEPES, pH 7, and 100 mM NaCl in phosphate-
buffered saline (PBS) by using a Gene Pulser II electroporator (Bio-Rad,
Hercules, CA) with a capacitance of 975 F and a voltage of 290 V. Cells were
plated out onto coverslips coated with 1 g/l fibronectin (Sigma-Aldrich, St.
Louis, MO) and 5 g/l collagen, and they were fixed at various times with
20°C methanol.
Antibodies
The following antibodies were used either for immunofluorescent staining or
Western blotting purposes: anti-pericentrin (M8) rabbit polyclonal (Doxsey et
al., 1994), anti-pericentrin B (gift from Trisha Davis as used in Mikule et al.,
2007) anti-RbAp46 (Abcam, Cambridge, MA), anti-CHD3 (Orbigen, San Di-
ego, CA), anti-CHD3 (gift from W. Wang) anti-CHD4 (Orbigen), anti-
CHD3/4 and anti-MTA2 (gifts from P. Wade). Secondary antibodies for
immunofluorescent staining were obtained from the following sources: anti-
mouse Alexa 488, anti-mouse AMCA and anti-rabbit Alexa 488 (all from
Invitrogen); anti-mouse Cy3, anti-rabbit Cy3, and anti-human Cy5 (all from
Jackson ImmunoResearch Laboratories, West Grove, PA). Horseradish per-
oxidase-linked anti-mouse and anti-rabbit secondary antibodies for Western
blotting purposes were obtained from GE Healthcare (Little Chalfont, Buck-
inghamshire, United Kingdom).
Immunoprecipitations and Western Blotting
Before lysis, cells were briefly washed with PBS, placed on ice, and excess
medium was removed by aspiration. Cells were lysed in either a low-strin-
gency buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 10 mM Na2HPO4, 1 mM
EDTA, pH 8, and 1% Triton X-100) or a high-stringency buffer (50 mM
Tris-HCl, pH 7.5, 150 mM NaCl, 1% sodium deoxycholate, 1% Triton X-100,
and 0.1% SDS). Lysates were cleared by centrifugation at 14, 000 rpm for 10
min at 4°C and then added to antibodies that had been incubated with 25 l
of protein A/G beads (Santa Cruz Biotechnology, Santa Cruz, CA) for 30 min
on ice. Proteins were immunoprecipitated overnight at 4°C with gentle mix-
ing, the beads washed were five times with low-stringency lysis buffer, and
then they were resuspended in 50 l of 2X SDS sample buffer. Proteins were
denatured at 90°C for 3 min, fractionated on SDS polyacrylamide gels, and
transferred to Immobilon membrane (GE Healthcare). Membranes were
blocked with 01.% Tween 20, 5% nonfat dried milk in PBS for 1 h at room
temperature, and incubated with primary antibodies diluted either in the
same buffer or 5% bovine serum albumin (BSA), PBS, and 0.1% Tween 20 for
2 h at ambient temperature or overnight at 4°C. Blots were washed four times
with 0.1% Tween 20, 5% nonfat dried milk in PBS, incubated with secondary
antibodies diluted in the same buffer for 1 h at ambient temperature, and
washed three times with 0.2% Tween 20 in PBS. Revelation of blots was
carried out using enhanced chemiluminescent development (Kirkegaard and
Perry Laboratories, Gaithersburg, MD).
Immunofluorescence Staining
Cells were grown on 12-mm acid-washed circular coverslips and fixed with
either 20°C methanol or 3.7% paraformaldehyde for 10 min at room tem-
perature. Fixed cells were rehydrated by sequentially washing in PBS and
then with a buffer consisting of PBS, 1% BSA, and 0.5% Triton X-100 (PBSA).
Antibodies were diluted in PBSA, pipetted onto the surface of the coverslip,
and incubated at room temperature for 1 h. The cells were washed with PBSA,
secondary antibodies diluted in the same buffer were added, and then cells
were incubated for 30 min at room temperature. DNA was stained using 1
g/ml 4,6-diamidino-2-phenylindole (DAPI) (Sigma-Aldrich).
Small-interfering RNA (siRNA)
The following duplexes were synthesized for the purpose of gene silencing:
CHD3, AAGCGUGACAGUGAGGAGGAA and AAGGCCAUCGAUCGGU-
UUAAU; CHD4, AAGGAUGAUGAUGAUGAUGAU and AACAGUUACC-
AAGAAGACUUA; MTA2, AACCGGUAUAUUCAGCAGAAA; and lamin,
AACUGGACUUCCAGAAGAACA (Dharmacon RNA Technologies, Lafay-
ette, CO); pericentrin and green fluorescent protein (GFP) siRNA have been
described previously (Mikule et al., 2007). Cells were transiently transfected
with siRNA at a final concentration of 200 nM by using oligofectamine
(Invitrogen) according to the protocol provided.
Immunofluorescence Microscopy and Live Cell Imaging
Images of cells were taken using a Lecia microscope equipped a 100 objec-
tive lens and a CoolSNAP camera (Princeton Instruments). Deconvolution
and fluorescence intensity measurements were carried out using MetaMorph
software (Molecular Devices, Downingtown, PA) according to previously
published protocols (Khodjakov and Rieder, 1999; Piehl et al., 2004). Briefly, a
1-m-diameter disk was placed over the centrosome, and the average fluo-
rescence intensity was measured within this area. In cases where it was
difficult to discern the location of the centrosome, regions were drawn onto an
image of -tubulin staining and then copied and pasted onto the images to be
measured. Live cell imaging was performed in 35-mm glass-bottomed dishes
overlaying medium with mineral oil (Sigma-Aldrich). A heated chamber
(Harvard Apparatus, Holliston, MA) perfused with CO2 was used to maintain
a temperature of 37°C, and constant pH. Images were taken every 5 min with
an Olympus microscope fitted with a 20 objective lens.
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RESULTS
Identification of CHD3 and CHD4 as
Pericentrin-interacting Proteins
To identify pericentrin-interacting proteins a region of
mouse pericentrin A, corresponding to residues 1340-1756
(Zimmerman et al., 2004), was used as bait in the yeast
two-hybrid system to screen a human testis cDNA expres-
sion library. Among the pericentrin-interacting clones iden-
tified was the C-terminal domain of CHD4 (residues 1577-
1912), a member of a protein family that localizes to the
nucleus, functions in transcriptional regulation and contains
two chromodomains and a SWI/SNF helicase domain
(Woodage et al., 1997). CHD3, a closely related member of
the chromodomain-SWI/SNF helicase family, also inter-
acted with pericentrin in the two-hybrid system (Figure 1A,
residues 1566-1966). Deletion-mapping (Supplemental Fig-
ure S1) showed that two pericentrin-interacting domains
existed between residues 1577-1733 and 1783-1912 within
the C-terminal fragment of CHD4 isolated in the yeast two-
hybrid screen. Sequence comparison of the C-terminal peri-
centrin-interacting region of CHD4 with that of CHD3 indi-
cated that these regions share 59% sequence identity and
72% similarity. Immunoprecipitation experiments con-
firmed the two-hybrid interactions. In COS-7 cells tran-
siently expressing hemagglutinin (HA)-tagged-pericentrin
and FLAG-tagged-CHD4, immunoprecipitation of FLAG-
CHD4 coprecipitated HA-pericentrin (Figure 1B). The ob-
served pericentrin doublet likely represents a cleavage prod-
uct (Golubkov et al., 2005a,b). We then showed that
overexpressed FLAG-CHD4 coprecipitated endogenous
pericentrin (Figure 1C), and conversely, that overexpressed
FLAG-tagged pericentrin coprecipitated endogenous forms
of both CHD3 and CHD4 (Figure 1D); the top band of the
CHD4 doublet could represent a posttranslationally modi-
fied form of the protein, potentially sumoylation, because
this has recently been demonstrated to occur in vitro (Gocke
et al., 2005). Finally, immunoprecipitation of endogenous
CHD3 and CHD4 from HeLa cell extracts coprecipitated
endogenous pericentrin (Figure 1E). Other NuRD compo-
nents were tested for their ability to interact with pericen-
trin. FLAG-tagged pericentrin expressed in COS cell copre-
cipitated a significant amount of the soluble MTA2 and less
of the soluble RpAp46 and MBD3. It is possible that RpAp46
and MBD3 interact with pericentrin with a lower affinity or
that they are transiently associated with the pericentrin–
CHD3/4 complex.
NuRD Components Localize to the Centrosome
It has been shown that a number of NuRD complex compo-
nents localize to the centrosome/spindle pole during mitosis,
including CHD3/4 (Mi2), MBD3, and HDAC1 (Chadwick
and Willard, 2002; Sakai et al., 2002). We reexamined these
results by investigating localization of NuRD components
throughout the cell cycle in RPE-1 cells by using antibodies
specific for CHD3, CHD4, MTA2, and RpAp46 (Figure 2,
A–D). The predominant location of all proteins in interphase
was the nucleus and to a lesser extent, the cytoplasm, but we
also detected distinct staining of CHD3, CHD4, and MTA2
at centrosomes (Figure 2, A–C, respectively). This staining
was enhanced when the cytoplasm was extracted with de-
tergent before fixation (data not shown). During prophase
the staining intensity of CHD3, CHD4, and MTA2 dimin-
ished in the nucleus. Centrosome staining of CHD3 and
MTA2 remained throughout mitosis, whereas the majority
of the centrosomal CHD4 seemed to dissociate; CHD3/4
and MTA2 also occurred at the midbody during cytokinesis.
RpAp46 did not localize to the centrosome at any cell cycle
stage, but it was enriched on the spindle during metaphase
(Figure 2D, middle). To determine whether NuRD compo-
nents were core components of centrosomes or whether they
simply accumulated at the minus ends of microtubules, we
examined their localization in the presence of the microtu-
bule depolymerizing drug nocodazole. In the absence of
centrosomal microtubules CHD3, CHD4, and MTA2 re-
tained their association with the centrosome in interphase
and mitosis, demonstrating a stable interaction with this
organelle (data not shown).
Figure 1. Components of the NuRD complex
interact with pericentrin. (A) Yeast strain
AH109, transformed with the C terminus of
either CHD3 (residues 1566-1966) or CHD4
(residues 1577-1912) and a C-terminal (C-ter)
region of pericentrin A (peri; residues 1340-
1756) grown on selective media to demon-
strate interactions (DBD, DNA binding do-
main; TAD, transactivation domain). (B) COS
cells cotransfected with HA-pericentrin (HA-
peri) and FLAG-CHD4 expression constructs.
Anti-FLAG or anti-GFP (control; Con) were
used for immunoprecipitations (IPs). IPs were
immunoblotted (IB) with antibodies as indi-
cated. (C) CoIP of endogenous pericentrin
with FLAG-CHD4 from transfected COS cell
lysates. (D) Immunoblots with antibodies to
CHD3, CHD4, MTA2, RpAp46, MBD3, and
FLAG after IP of FLAG-tagged pericentrin ex-
pressed in COS cells. (E) CHD3/4 was immu-
noprecipitated from HeLa cell lysates and im-
munoblotted for pericentrin or CHD3/4.
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Expression of the C Termini of CHD3 and CHD4 Displaces
Centrosomal Pericentrin
Pericentrin acts a scaffold for the -TuRC and kinases such
as PKA and PKCII at the centrosome (Dictenberg et al.,
1998; Young et al., 2000; Takahashi et al., 2002; Chen et al.,
2004; Zimmerman et al., 2004). To test whether pericentrin
served as a centrosomal scaffold for CHD3/4 and other
NuRD components, we attempted to disrupt the pericen-
trin–CHD3/4 interaction by expressing the pericentrin-in-
teracting C-terminal domains of CHD3 and CHD4 (CT-
CHD3 and -CHD4) in HeLa cells. We unexpectedly found
that pericentrin (not CHD3/4) was mislocalized from cen-
trosomes under these conditions (Figure 3). A significant
percentage (63–70%) of CT-CHD3– or CT-CHD4–express-
ing cells contained no detectable centrosomal pericentrin
(Figure 3B) or stained weakly possessing a tiny focus of
pericentrin staining. In contrast, control cells expressing GFP
mostly showed robust pericentrin staining that appeared as
one or two foci. The dramatic loss of centrosomal pericentrin
occurred rapidly (within 6 h) after electroporation of cDNA
encoding CT-CHD3, indicating that transcriptional activity
of the NuRD complex may not play a major role in the
centrosome disruption phenotype. In some cells, overex-
pressed CT-CHD3 and CT-CHD4 localized to the centro-
some, and these centrosomes showed a concomitant re-
duction in centrosomal pericentrin. This suggested that
centrosomal recruitment of overexpressed CT-CHD3 and
-CHD4 displaced or prevented the localization of pericentrin
at this site. Together these results indicate that the C termini
of CHD3 and CHD4 contain a functional pericentrin-binding
domain.
siRNA-mediated Depletion of CHD3 Mislocalizes
Centrosome Proteins
We next examined the effect of depleting CHD3 and CHD4
on centrosome integrity. siRNA targeting CHD3 or CHD4
showed depletion of the target protein by immunoblotting;
other NuRD components were not affected (Figure 4A).
Immunofluorescence analysis showed that target proteins
were partially depleted from nuclei and lost from centro-
somes in interphase cells (Figure 4, B and C). Cells depleted
of CHD3 showed reduced centrosomal staining with 5051, a
patient autoimmune serum that recognizes several centro-
some proteins, including pericentrin (Doxsey et al., 1994)
and centriolin (Gromley et al., 2003), indicating that these
proteins were lost from the centrosome (Figure 4B). Fluores-
cence intensity measurements of centrosomal 5051 and
CHD3/4 labeling indicated that RNA interference (RNAi) of
the CHD3 gene resulted in a significant reduction in 5051
levels at the centrosome (p  0.001, two-tailed test). In
comparison, 5051 levels were only slightly reduced after
treatment with CHD4 siRNA (p  0.05) (Figure 4, D and E).
Figure 2. NuRD components localize to cen-
trosomes and midbodies. (A–D) RPE-1 cells at
the indicated cell cycle stages were stained
with antibodies against the NuRD compo-
nents CHD3 (A), CHD4 (B), MTA2 (C), and
RbAp46 (D) (green), a centrosomal marker (-
tubulin or human autoimmune serum 5051;
red) and DAPI (DNA; blue). Antibodies to all
NuRD components except RbAp46 stained
centrosomes of interphasic cells. CHD3 and
MTA2 centrosomal staining was observed at
all mitotic stages, whereas CHD4 seem to dis-
sociate from the centrosome during mitosis.
Central spindle and midbody staining during
anaphase and telophase was also observed.
Bars, 10 m.
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In fact, pericentrin immunofluorescence images and quanti-
tative analysis showed that pericentrin was lost from cen-
trosomes in cells depleted of CHD3 (p  0.001; Figure 5, A
and B). Surprisingly, increased centrosomal pericentrin lev-
els were observed in cells treated with siRNA targeting
CHD4 compared with lamin A/C siRNA-treated control
cells (p  0.001; Figure 5, A and B). Other experiments
demonstrated that the level of -tubulin, a centrosome pro-
tein that binds pericentrin through its association with the
-tubulin ring complex (Zimmerman et al., 2004), was sig-
nificantly reduced at the centrosome upon treatment with
siRNA against CHD3 (p  0.001), whereas a marginally
significant reduction was observed upon CHD4 siRNA
treatment (p  0.05). This suggested that disruption of cen-
trosomal pericentrin displaced a fraction of -tubulin from
interphase centrosomes (Zimmerman et al., 2004) and that
other proteins likely anchor the remaining fraction of -tu-
bulin to interphase centrosomes (Takahashi et al., 2002).
Centrin-1 staining in CHD3-depleted cells was not different
from controls, indicating that the core structure of the cen-
trosome (centrioles) was still intact (Figure 5E). These re-
sults, combined with those from transient transfection
CHD3 and CHD4 C-termini, suggest that both proteins are
able to interact with pericentrin. However, the data suggests
that CHD3 is responsible for anchoring multiple compo-
nents to the centrosome, including pericentrin, as siRNA-
mediated depletion of the protein resulted in reduced cen-
trosomal levels of pericentrin, -tubulin, and 5051 antigens.
In contrast, loss of CHD4 resulted in increased centrosomal
pericentrin levels, suggesting that this protein is a negative
regulator and that it is involved in the displacement of
pericentrin from the centrosome (Figure 5, A and B). It is
likely that the overexpression of the CHD3/4 pericentrin-
binding domains, which share 92% homology, disrupts the
endogenous complexes at the centrosome, altering the bal-
ance of their activities and ultimately results in the loss of
centrosomal proteins.
CHD3 Is Required for Centrosome Anchoring of
Pericentrin and CHD4
It was clear from the above-mentioned experiments that
centrosomal-anchoring of pericentrin was dependent upon
the presence of CHD3; however, it was uncertain as to
whether CHD3/4 required each other to associate with the
centrosome. To address this question we silenced the CHD3
and CHD4 genes independently by RNAi, and we examined
the localization pattern of each protein by using antibodies
specific to CHD3 or CHD4 (Figure 6, A and B). The results
Figure 3. Overexpression of the C terminus (CT) of
CHD3 or CHD3 induces loss of pericentrin from centro-
somes in interphase cells. (A) HeLa cells electroporated
with myc-tag constructs expressing the C terminus of
CHD3 or CHD4 or a control plasmid (GFP), plated onto
fibronectin/collagen-coated coverslips, fixed in 20°C
methanol 6 h later, and stained with anti-myc to detect
overexpressed protein (red) or pericentrin (green) with
the exception of GFP control where transfected cells
were stained with an anti-pericentrin antibody and a
Cy3 secondary (red). In most cases, pericentrin was
either undetectable (at arrowheads) or reduced at cen-
trosomes (boxes) in cells expressing CT-CHD3 or CT-
CHD4 compared with control GFP-expressing cells
(row 1) or nontransfected cells (column 2). In some
cases, overexpressed CT-CHD4 localized to the centro-
some (left cell). Insets show enlargements of boxes. (B)
Quantification of results from A show that 70% of
CT-CHD3/4-expressing cells have barely detectable
pericentrin with centrosomal levels being 50% lower
than the average ( average). The remainder possessed
more than 50% of the average centrosomal pericentrin
level ( average). Bar, 10 m.
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showed that CHD3 RNAi significantly depleted the fraction
of CHD4 located at the centrosome but that it did not dra-
matically alter the localization pattern of CHD4 within the
nucleus, as judged by centrosomal fluorescence intensity
measurements (p  0.001; Figure 6, A and C). In contrast,
CHD4 RNAi seemed to have no effect upon the localization
of CHD3 with the centrosomal and nuclear fractions remain-
ing unperturbed. In support of this, fluorescence intensity
measurements showed that there was no significant differ-
ence in the level of CHD3 at the centrosome after CHD4
RNAi compared with a lamin A/C RNAi control (p  0.05;
Figure 6D). These data combined with the results presented
in Figure 5 suggest that CHD3 is a centrosomal protein
essential for anchoring pericentrin and CHD4 to the centro-
some. The data also indicate that CHD4 plays a role in
negatively regulating the amount of pericentrin at the cen-
trosome, because CHD4 RNAi resulted in increased centro-
somal levels of pericentrin. It is interesting to note that the
localization patterns of CHD3 and CHD4 differ slightly dur-
ing mitosis, with CHD3 remaining associated with the cen-
trosome, whereas CHD4 seems to dissociate from the or-
ganelle. Thus, it is tempting to speculate that CHD4 is a
factor controlling, in part, the mitotic accumulation of peri-
centrin at the centrosome. We next asked whether pericen-
trin depletion affected the centrosome localization of CHD3.
In cells depleted of pericentrin no change in the centrosome
levels of CHD3 were observed (Figure 7A). Quantification of
these centrosomes showed that despite a significant decrease in
pericentrin at centrosomes, CHD3 centrosome levels were only
marginally reduced (p 0.001; Figure 7B). This indicated that:
CHD3-anchored pericentrin to centrosomes, pericentrin did
not play a role in NuRD anchoring at the centrosome, and
pericentrin and the NuRD complex were not mutually depen-
dent in their centrosome localization.
Microtubule Organization and Regrowth Is Altered in
CHD3 siRNA-treated Cells
CHD3/4-dependent mislocalization of centrosomal pericen-
trin and -tubulin, which both play a role in microtubule
nucleation and organization (Zimmerman et al., 2004), sug-
Figure 4. RNAi-mediated depletion of
CHD3 but not CHD4 disrupts centrosome in-
tegrity. (A) RPE-1 cells treated with siRNAs
targeting CHD3, CHD4 or lamin (control) for
72 h were lysed and IB for the indicated pro-
teins. Note specific reduction of the targeted
protein, but not others. Pericentrin levels un-
affected under all conditions. (B and C) Cells
treated with siRNAs targeting CHD3, CHD4,
or lamin A/C were fixed in 20°C methanol
and stained with antibodies to CHD3, CHD4,
or 5051 (centrosome marker). In many cells
(80%), CHD3 and CHD4 were depleted from
nuclei and centrosomes. In cells depleted of
CHD3, a decrease in 5051 autoantibody stain-
ing was observed (B, middle image of left
column), suggesting a loss of many of the
proteins known to react with this human au-
toimmune serum. In contrast, depletion of
CHD4 did not show significant loss of 5051
staining (C, middle image of left column). (D
and E) Results of fluorescence intensity mea-
surements plotting centrosomal 5051 levels
against those of CHD3 or CHD4. After siRNA-
mediated silencing of the CHD3 gene, both
CHD3 and 5051 levels were reduced com-
pared with lamin A/C siRNA-treated control
cells (average CHD3 levels after CHD3 RNAi,
1182.9 arbitrary units (a.u.); lamin A/C RNAi,
2715.3 a.u; average 5051 levels after CHD3
RNAi, 1433.7 a.u; lamin A/C RNAi, 3834.0
a.u.). A slight reduction in the level of centro-
somal 5051 was observed after treatment with
CHD4 siRNA (average CHD4 levels after
CHD4 RNAi, 1050.1 a.u.; lamin A/C RNAi,
2070.8 a.u.; average 5051 levels after CHD4
RNAi, 4343.7 a.u.; lamin A/C RNAi, 5256.2
a.u.). Bars, 10 m.
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gested a role for the NuRD complex in these processes. We
first examined microtubule organization in cells expressing
the C termini of CHD3 and CHD4 after nocodazole treat-
ment and release. Six hours after electroporation of cDNAs
Figure 5. CHD3 depletion reduces centrosomal levels of pericentrin and -tubulin but not centrin. (A) HeLa cells treated with siRNAs
against CHD3, CHD4, or lamin A/C (control) for 48 h were fixed in 20°C methanol and stained with antibodies to CHD3/4 (red) and
pericentrin (green). Silencing of CHD3 (left) but not CHD4 or lamin (middle and right) induced loss of centrosomal pericentrin. (B) Results
of fluorescent intensity measurements quantifying pericentrin levels showed that CHD3 RNAi induced a loss of pericentrin from the
centrosome (p  0.001), whereas levels were elevated after CHD4 RNAi (p  0.001). Average centrosomal pericentrin levels were as follows:
after CHD3 RNAi, 1142.9 a.u.; CHD4 RNAi, 12,964.1 a.u.; and lamin A/C RNAi 5784.6 a.u. (C) HeLa siRNA-treated cells from experiment
in A were stained with antibodies to CHD3 or CHD4 (red) and -tubulin (green). Insets show enlarged images of centrosomal -tubulin. (D)
Centrosomal -tubulin levels were quantified by taking fluorescence intensity measurements and found to be significantly reduced after
CHD3 RNAi (p  0.001). The -tubulin levels were only slightly reduced after CHD4 RNAi (p  0.05 marginally significant). Average
-tubulin levels were as follows: after CHD3 RNAi, 2408.7 a.u.; CHD4 RNAi, 4118.6 a.u., and lamin A/C RNAi, 4904.4 a.u. (E) RPE-1 cells
treated with siRNAs as in A for 72 h were fixed and stained with antibodies to CHD3 or CHD4 (red) and centrin-1 (green) to label centrioles.
Insets show enlarged images of centrin-1 staining, which was similar under all conditions. Bars, 10 m.
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encoding the C termini of CHD3 or CHD4, microtubule
organization was dramatically perturbed in 84% of RPE
cells, whereas only 3% of GFP-transfected cells showed any
change in microtubule organization (Figure 8A). Cells
showed a dramatic reduction in the total number of micro-
tubules, which usually formed a random meshwork rather
than a radial array as seen in GFP-expressing controls. More-
over, the cells were more rounded compared with controls
presumably due to disruption of the microtubule cytoskel-
eton. These data suggested that overexpression of the
CHD3- or CHD4 C termini disrupted microtubule arrays by
displacing centrosomal components and consequently com-
promising the ability of centrosomes to organize microtu-
bule arrays. Profound defects in microtubule organization
and microtubule nucleation were observed when CHD3 was
depleted (Figure 8B). Sixty-three percent of CHD3 siRNA-
treated cells showed phenotypes consistent with defects in
microtubule nucleation, anchoring, and general organiza-
tion. Because protein depletion occurs in only 75–80% of the
cell population, the penetrance of the microtubule disrup-
tion phenotype seemed to be near complete. CHD3-depleted
cells had microtubules that were fewer in number, not prop-
erly organized into radial arrays, and absent from large
areas of the cytoplasm. In addition, a slight delay in nucle-
ation was observed 5 min after nocodazole washout. Micro-
tubules were sometimes organized into asters independent
of centrosomes or formed bundles at the cell periphery,
suggesting that they had been nucleated ectopically at these
sites or that they were originally organized by centrosomes
and subsequently released (Figure 7B). Centrosome-nucle-
ated asters had fewer microtubules, many of which seemed
to have lost their centrosome attachment (Figure 8B, 5 min).
When present, centrosome-anchored microtubules were as
long as controls, suggesting that their polymerization rate
was unaltered (Figure 8B and Supplemental Figure S3). Ad-
ditional images of regrowing microtubules in CHD3 siRNA-
treated cells are shown in Supplemental Figure S3. Micro-
tubules were often found at the cell periphery unattached to
centrosomes, suggesting that they had been nucleated ec-
topically at these sites or that they were centrosome nucle-
ated, released, and transported to these sites (Supplemental
Figure S3). Nuclei were often displaced from a central posi-
tion presumably from loss of microtubule organization. Ten
minutes after nocodazole washout, microtubules seemed to
be dramatically curved at the cell periphery and often
formed bundles around the nucleus (Figure 8B, bottom).
Some CHD4-depleted cells exhibited poorly formed micro-
tubule arrays (24%), a significantly higher percentage than
lamin siRNA-treated cells (1–2%), but neither ectopic micro-
tubule nucleation nor a delay in nucleation was observed
after 5 min of regrowth.
CHD3 Depletion Causes Mitotic Defects and Cytokinesis
Failure
We next investigated the effect of CHD3 depletion on mitotic
spindle integrity and function. Reduction of CHD3 levels
induced spindle defects in 59.6% of mitotic cells (Figure 9
and Supplemental Figure S2). The most prominent pheno-
type was a disrupted prometaphase-like configuration with
a dramatic reduction in spindle microtubules and misalign-
ment of chromosomes within spindles (Figure 9A). We also
observed significant numbers of spindles in which the cen-
Figure 6. Anchoring of CHD4 to the centro-
some is dependent upon CHD3. (A and B)
RPE-1 cells were treated with siRNA against
CHD3, CHD4, or lamin A/C for 72 h, fixed,
and stained with either anti-CHD4 (A) or anti-
CHD3 (B) and anti--tubulin antibodies. (C)
Fluorescence intensity measurements showed
that silencing of the CHD3 gene resulted in a
significant reduction in the amount of CHD4
at the centrosome (p 0.001), but they did not
seem to affect the nuclear pool of this protein.
The average level of centrosomal CHD4 in
lamin A/C control RNAi-treated cells was
2024.7 a.u. compared with 1234.5 a.u. in CHD3
RNAi-treated cells. (D) Cells treated with
siRNA against CHD4 still possessed CHD3 at
the centrosome with levels remaining un-
changed compared with lamin A/C siRNA-
treated controls (p   0.05). The average
fluorescence intensities were 2756.0 a.u. and
2715.2 a.u. for CHD4 and lamin A/C siRNA-
treated cells, respectively. Bars, 10 m.
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trosomes had separated giving rise to a bipolar spindle, but
only one pole seemed to nucleate microtubules (referred to
as half-spindles in the legend of Figure 9). Monopolar spin-
dles, tripolar spindles and lagging chromosomes were often
observed. In contrast, such spindle defects were observed in
only 3.6% of the control HeLa cell population (lamin A/C
siRNA treated) and 14.4% in CHD4-depleted cells (Figure
9B). The percentage of spindle defects in CHD4-depleted
cells was significantly higher than controls but less than
CHD3-depleted cells, and it did not include the predomi-
nant prometaphase-like defects seen after CHD3 depletion.
Consistent with the apparent loss of microtubule polymer in
spindles of CHD3 depleted cells was a reduction in the
amount of -tubulin at the spindle poles and on the spindle
(Figure 9C). There seemed to be a selective loss of -tubulin
from the poles as the total cellular level of the protein,
assessed by immunoblotting, was similar to controls (data
not shown). Spindle pole levels of -tubulin in CHD4-de-
pleted cells were similar to controls, suggesting that the
modest increase in microtubule disorganization and spindle
defects seen in these cells occurred by a mechanism distinct
from the CHD3-induced defects. To further investigate the
fate of CHD3-depleted cells during mitosis, we performed
time-lapse imaging by using phase contrast microscopy.
Cells were continuously examined for 23–28 h (Figure 10
and Supplemental Movies S1 and S2). Control cells (lamin
A/C depleted) completed the transition from cell rounding
to anaphase in 37.8 min, and 27/28 completed mitosis nor-
mally (Figure 10, A and D); one cell formed a tripolar spin-
dle and gave rise to three progeny. In contrast, CHD3-
depleted cells that completed cell division took an average
of 265 min to transit the same time period. Many CHD3-
depleted cells failed to segregate their chromatids, exited
mitosis, and reattached to the substrate as mononuclear
polyploid cells (Figure 10C). Others attempted to divide but
failed in cytokinesis to form binucleated cells (Figure 10B).
Whereas all control cells entered mitosis during the time that
cells were examined, only half of the CHD3-depleted cells
entered mitosis in the same time frame. This suggested a
delay at a cell cycle stage before mitosis. CHD3-depleted
cells that failed cytokinesis sometimes entered a second
round of division. Defects at multiple stages of cytokinesis
are consistent with general disorganization of microtubules
in CHD3-depleted cells.
DISCUSSION
Identification of Novel Pericentrin-interacting Proteins
We have shown that pericentrin interacts with members of
the NuRD complex and that the NuRD components CHD3,
CHD4, and MTA2 localize to centrosomes during inter-
phase. Differences in the localization patterns of NuRD com-
ponents during mitosis were observed; CHD3 and MTA2
remained associated with the centrosome, whereas most of
the CHD4 dissociated and was present at a reduced level
from metaphase until telophase. Other NuRD components
have been shown to localize to spindle poles (MBD3,
HDAC1) (Chadwick and Willard, 2002; Sakai et al., 2002),
suggesting the entire complex may be located at this site, in
addition to its nuclear localization.
Pericentrin–NuRD Complexes
Our results suggest that pericentrin interacts with a subset of
NuRD components, indicating that this complex may be
different from other NuRD complexes. There is some con-
troversy within the chromatin field as to whether CHD3 is
present within the NuRD complex. Zhang et al. (1998) iso-
lated NuRD complexes from HeLa nuclear extracts and
identified 43 peptides by mass spectrometric analysis, the
majority of which corresponded to sequences conserved
between CHD3 and CHD4, although four peptides specifi-
cally derived from CHD4 (Mi2), but none from CHD3,
were identified (Zhang et al., 1998). Other groups found that
CHD3 was present in the NuRD, but it was less abundant
than CHD4, suggesting that CHD3 either formed distinct
complexes or it was a minor component of the NuRD (Tong
et al., 1998; Wade et al., 1998; Xue et al., 1998). Together, these
data suggest that pericentrin forms a complex with CHD3
that is distinct from the NuRD. Differences in the abun-
dances of NuRD components within the pericentrin complex
support this argument, because low amounts of MBD3 and
RpAp46 were found to be present, suggesting that these
were not core components or interacted weakly. Our data
Figure 7. Pericentrin is not required for CHD3 centrosomal local-
ization. (A) RPE-1 cells were treated with siRNA against pericentrin
or GFP for 72 h, fixed, and stained with anti-CHD3 (green), anti-
pericentrin (red) and anti--tubulin (blue) antibodies. Insets show
enlargements of the centrosomal areas marked with boxes. Deple-
tion of pericentrin did not significantly alter the localization of
CHD3 to the centrosome. (B) Quantification of pericentrin and
CHD3 levels at the centrosome by measuring fluorescence intensity.
Pericentrin levels were reduced upon RNAi, but CHD3 levels re-
mained virtually unchanged. Bars, 10 m.
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also indicate that CHD3 and CHD4 probably form different
complexes with pericentrin, which have alternative func-
tions. CHD3 seems to play a role in anchoring proteins at the
centrosome both in interphasic and mitotic cells, whereas
CHD4 seems to modulate the amount of protein at the
centrosome, but it is not directly involved in protein anchor-
age at this site.
Does CHD3 Directly Anchor Pericentrin at Centrosomes?
Our transient transfection experiments support a direct role
for CHD3/NuRD in anchoring pericentrin to the centro-
some. The overexpression of the pericentrin-binding do-
mains of either CHD3 or CHD4 displaced endogenous peri-
centrin from the centrosome within 6 h, a time that is likely
too short to significantly alter gene expression. Furthermore,
overexpressed proteins were distributed throughout the cy-
toplasm, and presumably they did not disrupt the function
of the NuRD complex within the nucleus, because they did
not localize to this cellular compartment. However, it is
difficult to exclude an alternative model whereby expression
of pericentrin or another protein associated with controlling
pericentrin function is transcriptionally regulated by the
NuRD. Our results also demonstrate that pericentrin deple-
tion does not perturb centrosomal CHD3, showing a lack of
codependence in centrosome localization and providing fur-
ther evidence for an anchoring function for CHD3.
A Link between the Centrosome and Nucleus?
The interaction between pericentrin, a centrosomal protein,
and CHD3/4 and MTA2, components of a nuclear complex
is not without precedence. This interaction joins a growing
list of liaisons between nuclear and centrosomal proteins.
For example, centrin-2 is part of the XPC, transforming
acidic coiled-coil (TACC) proteins 1–3 directly bind to the
histone acetyltransferase hGCN5L2, the Drosophila protein
CP190 forms part of the gypsy chromatin insulator, and
hEg5 is within an N-CoR repressor complex (Araki et al.,
2001; Yoon et al., 2003; Gangisetty et al., 2004; Pai et al., 2004;
Doxsey et al., 2005). These complexes have a diverse range of
functions. XPC is involved in nucleotide excision repair, and
it is responsible for detecting damaged DNA in global ge-
nome nucleotide excision repair. The role of hEg5 within the
N-CoR repressor complex, if it is a genuine component, is
unknown. CP190 was found to be an essential component of
Figure 8. Microtubule organization and nu-
cleation is diminished in cells overexpressing
or depleted of CHD3. (A) RPE-1 cells were
electroporated with myc-tagged CHD3 or
CHD4 C terminus or GFP as a control. Cells
were fixed 6 h after transfection and stained
with anti--tubulin and anti-myc antibodies.
Cells transfected with either the C terminus of
CHD3 or CHD4 possessed fewer and more
disorganized microtubule arrays compared
with GFP controls with 84%, in each case,
exhibiting the phenotype shown. In contrast
only 3% of GFP-transfected cells had a disor-
ganized microtubule array. (B) Time course of
microtubule regrowth. Cells depleted of
CHD3, CHD4, or lamin (control) for 40 h were
treated with nocodazole for 90 min; washed
free of drug; fixed at 2-, 5-, and 10-min time
intervals; and stained for microtubules (red),
centrosomes (5051 autoimmune serum; green)
and DNA (blue). Note fewer centrosome-nu-
cleated microtubules (column 1, middle) and
the curved, unfocused microtubules (column
1, bottom). One microtubule aster (right box,
first column) is not associated with a centro-
some. Percentages refer to number of cells
having disrupted microtubule arrays. Bars
10 m.
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the gypsy chromatin insulator and localizes to centrosomes,
although mutation of this gene seemed to have no effect
upon centrosome function (Pai et al., 2004). Human TACC
proteins localize to the nucleus and centrosome, although
TACC1 and -3 associate with the centrosome only during
mitosis (Gergely et al., 2000). In contrast, TACC proteins are
involved in microtubule organization, and they enhance
recruitment of microtubules to the mitotic spindle (Gergely
et al., 2000). Alternatively, they seem to regulate gene ex-
pression via their interaction with the HAT hGCN5L2,
which associates with chromatin remodeling components
(Gangisetty et al., 2004). Abnormal expression of TACC pro-
teins contributes to the development of multiple myeloma,
breast and gastric cancer, an effect that could occur via two
different mechanisms, aberrant gene expression or spindle
dysfunction (Gergely et al., 2000; Conte et al., 2002, 2003;
Gangisetty et al., 2004). Thus, there are clear parallels be-
tween TACC proteins and CHD3/4, because both have sim-
ilar localization patterns, play roles in transcription regula-
tion and alter microtubule patterns. Together, these results
indicate that nuclear proteins play a role in regulating the
activity of the centrosome.
Does Pericentrin Regulate Gene Expression?
RNAi experiments demonstrated that the nuclear protein
CHD3 anchors pericentrin to the centrosome and affects
microtubule and spindle function, which provokes the ques-
tion, Does the centrosome protein pericentrin function in the
nucleus? A recent study demonstrated that cells treated with
leptomycin B, an inhibitor of nuclear export, induced accu-
mulation of pericentrin within the nucleus (Keryer et al.,
2003). This indicates that pericentrin is able to traverse the
nuclear envelope but that it is rapidly shuttled out of this
compartment and might have a function within the nucleus.
Other evidence suggests a role for pericentrin in the nu-
cleus. A NuRD complex containing MTA3 has recently been
found to play a role in governing the expression of the
E-cadherin by controlling the level of Snail, a transcriptional
repressor of this gene. A cDNA encoding a protein sharing
homology with the transcriptional repressor kaiso was also
identified as a pericentrin-interacting protein in the yeast
two-hybrid screen (Sillibourne and Doxsey, unpublished
observation). If this kaiso-like protein is a bona fide inter-
acting protein, it would further support the idea that peri-
centrin plays a role in regulating gene expression by associ-
ating with specific transcription factors and components of
the NuRD complex. Moreover, a recent article demonstrat-
ing that pericentrin colocalizes with overexpressed SUMO in
small nuclear dots suggests that pericentrin interacts with or
is modified by the small ubiquitin modifier (SUMO) (Cheng
et al., 2006). In addition, there is evidence providing a link
between SUMO and CHD3. A yeast two-hybrid screen for
Figure 9. CHD3 depletion induces mitotic
spindle defects. (A) HeLa cells treated with the
indicated siRNAs for 48 h were fixed with
20°C methanol and stained with anti--tu-
bulin (red) and 5051 (green, centrosomes) an-
tibodies. CHD3 depletion (top) resulted in
poorly organized spindles, misaligned chro-
mosomes, and bundled microtubules com-
pared with CHD4 and lamin A/C siRNA-
treated cells (bottom). Also see Supplemental
Figure 2. Insets, 5051-labeled centrosomes. (B)
Quantification of spindle defects in siRNA-
treated cells. Defects, which include abnormal
prometaphase-like phenotype (specific for
CHD3), monopolar-, tripolar-, and half-spin-
dles and spindles with lagging chromosomes,
are 60% in CHD3-depleted cells. Other cat-
egories indicate the percentage of cells in each
phase of mitosis that seem to be undergoing
normal division (cyto, cytokinesis; telo, telo-
phase; ana, anaphase; meta, metaphase; pro-
meta; prometaphase; and pro, prophase). n 
100–200 mitotic cells counted for each condi-
tion. (C) -Tubulin staining in CHD3-depleted
mitotic HeLa cells was reduced on poles and
spindles and increased in the cytoplasm when
compared with CHD4- and lamin AC-de-
pleted cells. Bars, 10 m.
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p73-interacting proteins identified SUMO and CHD3 as po-
tential partners; subsequent cross tests demonstrated that
the C terminus of CHD3 interacted with SUMO (Minty et
al., 2000). CHD3 and CHD4 have been recently identified
as a target of SUMO modification in vitro, indicating that
these proteins are potentially modified in vivo (Gocke et
al., 2005). In this article, we have presented evidence
demonstrating that CHD3/4 are centrosomal proteins and
both play a role in controlling the amount of pericentrin,
and possibly other components, at the centrosome. RNAi
experiments indicate that ablation of CHD4 protein
causes an increase in the amount of pericentrin anchored
at the centrosome, suggesting that this protein is a nega-
tive regulator of pericentrin. In contrast, CHD3 RNAi
reduces the amount of pericentrin at the centrosome, a
surprising result given that CHD4 levels are also dimin-
ished by this treatment. More pericentrin would have
been expected to localize to the centrosome after the
CHD3 RNAi-induced loss of CHD4. This result suggests
that CHD3 is a key centrosome component required for
the anchoring of pericentrin, -tubulin, and CHD4 to the
centrosome. We favor a model whereby CHD3 acts as a
structural anchor keeping pericentrin and CHD4 at the
centrosome and CHD4 is responsible for regulating or
fine-tuning the removal of pericentrin from the centro-
some. It is interesting to note that during mitosis CHD4
dissociates from the centrosome, whereas CHD3 remains
associated, and pericentrin levels rise steadily throughout
mitosis until entry into G1, upon which they fall dramat-
ically. The dissociation of CHD4 from the centrosome is,
perhaps, a prerequisite for the recruitment of pericentrin
to the centrosome during mitosis. Several questions re-
main unanswered, including how is CHD3 anchored to
the centrosome and how do CHD3 and CHD4 cooperate
to regulate centrosome function? Finding the molecule to
which CHD3 binds to at the centrosome may shed light on
the function of this protein and help build a picture of the
structural makeup of this multicomponent complex. How
CHD4 regulates pericentrin levels at the centrosome is an
open question, but it is tempting to speculate that post-
translational modification may play a role; perhaps
through cycles of acetylation or decetylation or may be via
SUMOylation. The answers to these questions will help to
unravel the mechanism by which the helicases CHD3 and
Figure 10. CHD3 depletion causes metaphase delay,
mitotic failure, and cytokinesis defects. Still images from
time-lapse movies (see Supplemental Movies) of HeLa
cells depleted of lamin A/C (A, control) or CHD3 (B and
C). Image collection was initiated 24 h after siRNA treat-
ment and continued for 22 h. (A) Successful mitosis in
lamin A/C-depleted cell. (B) Mitotic CHD3-depleted cell
(time 0 h 00 min) enters anaphase (2 h 45 min) and seems
to complete telophase (4 h 00 min), but ultimately it fails
cytokinesis to become a binucleated cell (14 h 40 min). (C)
Another CHD3-depleted cell (arrowhead) enters meta-
phase (18 h 40 min) and exits mitosis without dividing (20
h 40 min). (D) Graph showing timing of individual cells
from nuclear envelope breakdown (NEB) to anaphase on-
set: 38 min in lamin A/C-depleted cells (range 15–110
min) and 265 min in CHD3-depleted cells (range 40–435
min). Bar, 10 m.
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CHD4 control the localization of their centrosomal part-
ners and regulate centrosome function.
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